The Trump administration mishandled the initial distribution of the only approved coronavirus medication, delaying treatment to some critically ill patients with COVID-19, the disease caused by the virus, according to nine current and former senior administration officials. The first tranche of 607,000 vials of the antiviral medication remdesivir, donated to the government by drugmaker Gilead […]
This story is from The Seattle Times. Read the rest of this News story at https://www.seattletimes.com/nation-world/administration-initially-dispensed-scarce-covid-19-drug-to-some-hospitals-that-didnt-need-it/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news.
This post was originally published on this site